Showing results (1291-1300 of 1,386) with videos related to

Sort By:
Pageof 139
The Journal of Biological Chemistry|April 26, 2017
Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumabAnna M Davies, Elizabeth G Allan, Anthony H Keeble, et al.
Open Forum Infectious Diseases|July 25, 2025
An Observational Analysis of a Large Cohort of <i>Pneumocystis jirovecii</i> PneumoniaAaron M Pulsipher, Holenarasipur R Vikram, Michael B Gotway, et al.
Experimental Hematology|July 8, 2022
Germline ETV6 mutation promotes inflammation and disrupts lymphoid development of early hematopoietic progenitorsChengjing Zhou, Rizvan Uluisik, Jesse W Rowley, et al.
The British Journal of Dermatology|February 15, 2012
Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repairH D de Koning, E H van den Bogaard, J G M Bergboer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 14, 2014
Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritisAndrew J Kinloch, Anthony Chang, Kichul Ko, et al.
Journal of Neurology|October 8, 2020
Intravenous immunoglobulin therapy in COVID-19-related encephalopathyLorenzo Muccioli, Umberto Pensato, Giorgia Bernabè, et al.
Aging Cell|January 22, 2021
Interleukin-37 improves T-cell-mediated immunity and chimeric antigen receptor T-cell therapy in aged backgroundsJamie A G Hamilton, Miyoung Y Lee, Rae Hunter, et al.
Seizure|January 23, 2017
Ketogenic diet therapy for epilepsy during pregnancy: A case seriesElles J T M van der Louw, Tanya J Williams, Bobbie J Henry-Barron, et al.
American Journal of Veterinary Research|September 1, 2016
Phase I-II clinical trial of hyaluronan-cisplatin nanoconjugate in dogs with naturally occurring malignant tumorsShuang Cai, Ti Zhang, W C Forrest, et al.
Pageof 139